Generate a tailored SOP for Dr. Shohei Koide. Improve your application with a focused, well-structured draft.
Dr. Shohei Koide is a Professor at the Perlmutter Cancer Center and the Director of Cancer Biologics. His research focuses on controlling biological processes at the molecular level through the engineering of synthetic proteins. With a primary emphasis on the design and engineering of new protein functions, especially in target binding and the fundamental functions underlying various biological events, Dr. Koide employs a multi-disciplinary approach that integrates rational design, directed evolution, and structural cellular biology. His innovative work utilizing synthetic binding proteins allows for high-precision control over cellular regulatory mechanisms governed by allostery and post-translational modifications, including phospho-signaling and epigenetic regulation of membrane proteins. His extensive training includes a Ph.D. from the University of Tokyo and postdoctoral studies at The Scripps Research Institute where he specialized in Molecular Biophysics. His contributions to the field have established him as a leading figure in cancer therapeutics, particularly in the development of biologics aimed at targeting cancer-causing proteins.
Open Program in Biomedical Sciences (Vilcek Institute) covers departments like Biochemistry, Pathology, Neuroscience, Microbiology, etc.